Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-042340
Filing Date
2017-06-29
Accepted
2017-06-29 17:05:57
Documents
1
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14116
  Complete submission text file 0001209191-17-042340.txt   15435
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address BONTE KRAAILAAN 1 ALMERE P7 1343AJ
Business Address
Petry Harald (Reporting) CIK: 0001693830 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 17939253